EMERGENT BIOSOLUTIONS INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2017-11-03: Form 10-Q; Exhibit 10.2; Description Modification No. 5, effective September 8, 2017, to the Solicitation/Contract/Order for Commercial Items (the "CDC BioThrax Procurement Contract"), effective December 8, 2016, from the Centers for Disease Control and Prevention to Emergent Biodefense Operations Lansing LLC..
- 2017-10-02: Form 8-K; Exhibit 10; Description Credit Agreement, dated September 29, 2017, by and among Emergent BioSolutions Inc., the lenders party thereto from time to time, and Wells Fargo Bank, National Association, as the Administrative Agent..
- 2017-05-05: Form 10-Q; Exhibit 10.4; Description SIXTH AMENDMENT TO CREDIT AGREEMENT.
- 2017-05-05: Form 10-Q; Exhibit 10.3; Description Award/Contract (the "BARDA BioThrax Contract"), effective March 16, 2017, between the BioMedical Advanced Research and Development Authority and Emergent Biodefense Operations Lansing LLC..
| Filed | Form | Exhibit | Description |
|---|
| 2017-11-03 | 10-Q | 10.2 | Modification No. 5, effective September 8, 2017, to the Solicitation/Contract/Order for Commercial Items (the "CDC BioThrax Procurement Contract"), effective December 8, 2016, from the Centers for Disease Control and Prevention to Emergent Biodefense Operations Lansing LLC. |
|---|
| 2017-10-02 | 8-K | 10 | Credit Agreement, dated September 29, 2017, by and among Emergent BioSolutions Inc., the lenders party thereto from time to time, and Wells Fargo Bank, National Association, as the Administrative Agent. |
|---|
| 2017-05-05 | 10-Q | 10.4 | SIXTH AMENDMENT TO CREDIT AGREEMENT |
|---|
| 2017-05-05 | 10-Q | 10.3 | Award/Contract (the "BARDA BioThrax Contract"), effective March 16, 2017, between the BioMedical Advanced Research and Development Authority and Emergent Biodefense Operations Lansing LLC. |
|---|
| 2017-05-05 | 10-Q | 10.2 | Modification No. 1 to the Award/Contract (the "BARDA NuThrax Contract"), effective March 16, 2017, between the BioMedical Advanced Research and Development Authority and Emergent Product Development Gaithersburg Inc. |
|---|
| 2017-02-28 | 10-K | 10.24 | SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS |
|---|
| 2017-02-28 | 10-K | 10.6 | FIFTH AMENDMENT, LIMITED WAIVER AND |
|---|
| 2017-02-28 | 10-K | 10.5 | FOURTH AMENDMENT TO CREDIT AGREEMENT |
|---|
| 2017-02-21 | 8-K | 10 | Form of Performance-Based Stock Unit Award Agreement. |
|---|